We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

OBT Licenses BioWa’s POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer

News   Apr 07, 2011

 
OBT Licenses BioWa’s POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer
 
 
 

RELATED ARTICLES

Protein "Spat Out" by Cancer Cells Promotes Tumor Growth

News

Prostate cancer cells change the behavior of other cells around them, including normal cells, by 'spitting out' a protein from their nucleus.

READ MORE

Peptide May Protect Kidneys From Ourselves

News

A synthetic peptide appears to directly disrupt the destructive inflammation that occurs in nephritis, enabling the kidneys to better recover and maintain their important functions.

READ MORE

Bacteria Bide Their Time When Antibiotics Attack

News

If an antibiotic doesn’t kill all the bacteria that infects a patient, the surviving bugs may be particularly adept at timing their resurgence.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE